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Zurich, Switzerland
BACKGROUND & AIMS: Extended liver resection leads
to hepatic failure because of a small remnant liver
volume. Excessive parenchymal damage has been pro-
posed as the principal cause of this failure, but little is
known about the contribution of a primary deficiency
in liver regeneration. We developed a mouse model to
assess the regenerative capacity of a critically small liver
remnant. METHODS: Extended (86%) hepatectomy
(eHx) was modified to minimize collateral damage; ef-
fects were compared with those of standard (68%) par-
tial hepatectomy (pHx) in mice. Markers of liver integ-
rity and survival were evaluated after resection. Liver
regeneration was assessed by weight gain, proliferative
activity (analyses of Ki67, proliferating cell nuclear an-
tigen, phosphorylated histone 3, mitosis, and ploidy),
and regeneration-associated molecules. Knockout mice
were used to study the role of p21. RESULTS: Com-
pared with pHx, survival of mice was reduced after eHx,
and associated with cholestasis and impaired liver func-
tion. However, no significant differences in hepatocyte
death, sinusoidal injury, oxidative stress, or energy de-
pletion were observed between mice after eHx or pHx.
No defect in the initiation of hepatocyte proliferation was
apparent. However, restoration of liver mass was delayed
after eHx and associated with inadequate induction of
Foxm1b and a p21-dependent delay in cell-cycle progression.
In p21-/- mice, the cell cycle was restored, the gain in liver
weight was accelerated, and survival improved after eHx.
CONCLUSIONS: Significant parenchymal injury is not
required for liver failure to develop after extended hep-
atectomy. Rather, liver dysfunction after eHx results
from a transient, p21-dependent block before hepatocyte
division. Therefore, a deficiency in cell-cycle progression
causes liver failure after extended hepatectomy and can
be overcome by inhibition of p21.
Keywords: Liver Regeneration; Small-For-Size Syndrome;
Extended Hepatectomy; Liver Regeneration Failure.
The liver has a unique capacity to regenerate aftermajor tissue loss. However, a threshold exists for the
amount of residual tissue below which the liver does not
recover sufficiently to maintain vital function. Thus, after
extensive liver resection, a transient or sometimes fatal
form of hepatic failure may develop, characterized by
prolonged hyperbilirubinemia, reduced liver function,
and sometimes death within a few days. This entity,
known as Small-For-Size Syndrome (SFSS), currently is
untreatable and considerably limits surgical therapy of
many liver diseases.1,2
The pathophysiology underlying SFSS remains largely
unknown.3 It is particularly unclear whether the impaired
liver function is a result of disproportional tissue damage
after resection or is caused by a primary failure in regen-
eration of the small remnant. To study liver failure after
extended hepatectomy, several murine models have been
developed and suggest the accruement of damage is the
critical event leading to liver dysfunction after extensive
tissue loss.4–7 Accordingly, the presence of excessive post-
operative parenchymal injury and a pronounced early
mortality are features shared by all existing mouse models
of extended hepatectomy. However, the hepatic injury
observed in mouse models is of unproven physiological
significance and may confound the intrinsic capacity of a
small remnant to regenerate. To better investigate failure
of liver regeneration as a mechanistic factor after extended
hepatectomy, a mouse model is needed that is character-
ized by minimal tissue injury. Such a model could reduce
selection bias owing to early mortality, and may reveal
whether the small size per se imposes a barrier for liver to
initiate and progress through the regenerative process. To
this end, we designed a novel mouse model of liver failure
after extended hepatectomy with the following aims: (1)
to minimize collateral damage while maintaining features
reminiscent of human SFSS, and (2) to investigate pri-
mary liver regeneration in a small liver remnant.
Materials and Methods
Animals
All animal experiments were performed in accordance
with Swiss Federal Animal Regulations and approved by the
Abbreviations used in this paper: ATP, adenosine triphosphate; eHx,
extended 86% hepatectomy; LW/BW, liver weight to body weight ratio;
mRNA, messenger RNA; PCNA, proliferating cell nuclear antigen; pH3,
phosphohistone 3; pHx, partial 68% hepatectomy; SFSS, Small-For-Size
Syndrome; TUNEL, terminal deoxynucleotidyl transferase–mediated de-
oxyuridine triphosphate nick-end labeling.
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Veterinary Office of Zurich. Animals aged 10–12 weeks were
kept on a 12-hour day/night cycle with free access to food and
water. C57Bl/6 mice were obtained from Harlan (Horst, The
Netherlands), p21 knockout animals and corresponding wild
types (B6129SF2/J) were obtained from Jackson Laboratories
(Bar Harbor, ME).
Animal Surgery
Anesthesia was induced by isoflurane inhalation (2%–
4%), and preoperative subcutaneous application of buprenor-
phine (0.1 mg/kg bodyweight). Anesthetic depth was monitored
by clinical parameters (respiratory rate and depth, color of mu-
cous membranes and inner organs, movement, and reflexes).
After surgery, animals were allowed to recover on a warming pad
in a separate cage until completely conscious. For standard
hepatectomy (partial 68% hepatectomy [pHx]), a midline inci-
sion was performed, and the liver was freed from ligaments. The
pedicle of the left lobe was ligated (silk, 6/0), and resected. After
cholecystectomy (Prolene, 8/0; Ethicon, Neuchatel, Switzerland),
the middle lobe was ligated in 2 steps (silk 6/0) and resected. For
extended hepatectomy (extended 86% hepatectomy [eHx]), all
segmental portal vessels of the caudate, right anterior, left, and
middle lobes were ligated individually (Prolene 8/0) (Figure 1A
and B). The parenchyma was transected with silk 6/0 ligatures
afterward. Vascular and biliary structures of the right posterior
lobe were preserved by this technique and visually controlled.
Liver Weight to Body Weight Ratio
Liver regeneration was expressed by the ratio of liver
weight to body weight (LW/BW). Animal weight was measured
directly before harvesting.
Histologic Examination
H&E was performed on 3-m, paraffin-embedded sec-
tions of the liver. DNA fragmentation was visualized with fluo-
rescein–deoxyuridine triphosphate (terminal deoxynucleotidyl
transferase–mediated deoxyuridine triphosphate nick-end label-
ing [TUNEL]) using a Cell Death Detection Kit (Roche Applied
Science, Basel, Switzerland). Spleen sections served as TUNEL-
positive controls. Immunostainings were performed for Ki67 (Ab-
cam, Cambridge, United Kingdom), phosphohistone 3 (pH3;
Chemicon, Darmstadt, Germany), Mpo (NeoMarkers, Fremont,
CA), F4/80 (BMA Biomedicals, Augst, Switzerland), Vegfr3, Cd31
(BD Pharmingen, Allschwil, Basel), p27 (Santa Cruz, Santa Cruz,
CA), and proliferating cell nuclear antigen (PCNA; Abcam) using
the Ventana Discovery automated staining system and the iView
DAB kit (Ventana Medical Systems, Tucson, AZ), and counter-
stained with hematoxylin. The number of Ki67-positive and pH3-
positive hepatocytes was determined by manual counting in 20
random visual fields (200). To better visualize hepatic sinu-
soids (Vegfr3, Cd31), images were pseudocolored by desaturat-
ing and brightening all color unrelated to brown (DAB), fol-
lowed by color inversion using Adobe Photoshop (Adobe, San
Figure 1. Extended hepatectomy induces features of liver failure in mice. (A) Modified surgical procedure for the radical resection of mouse liver.
Segmental portal vein branches are ligated separately before parenchymal transection. (B) Ischemia of the ligated anterior right liver lobe before
parenchymal resection. (C) Serum bilirubin levels at 24 to 168 hours after resection. (D) Plasma alkaline phosphatase (ALKP) levels at 24, 48, and 168
hours after resection. Note the similar patterns for bilirubin and ALKP levels. (E) Serum albumin levels at 48 and 168 hours after resection. (F)
Kaplan–Meier estimates for the survival of mice after standard (pHx) or the modified extended (eHx) resection.
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Jose, CA). For immunofluorescence, p21 antibody (BD Pharmin-
gen) was detected using an Alexa Fluor 488–conjugated anti-
mouse secondary antibody (Invitrogen, Zug, Switzerland). All
histologic analyses were performed in a blinded fashion with
respect to the experimental groups.
Fluorescent Ki67 Analysis
Slides were incubated with fluorescein-labeled antibody
to Ki67 and stained with 4=,6-diamidino-2-phenylindole. The
percentage of proliferating hepatocytes was calculated by the
ratio of Ki67-positive nuclei per total 4=,6-diamidino-2-phenylin-
dole nuclei, excluding nuclei with a size less than 12 m (Imaris
Software, Bitplane, Zurich, Switzerland). Hepatocyte size was
calculated by the ratio of analyzed area per number of hepato-
cytes. Fields (1 mm2) were selected randomly and analyzed by the
software. On average, about 10,000 cells were assessed per sam-
ple. Vessels were excluded from the analysis.
Serum Alanine Aminotransferase and High-
Mobility Group Protein 1 Levels
Serum samples were obtained from the inferior vena
cava before organ harvesting after precipitation of blood cells.
Alanine aminotransferase levels were measured using a serum
multiple biochemical analyzer (Ektachem DTSCII; Johnson &
Johnson, Inc, Rochester, NY). High-mobility group protein
1–enzyme-linked immunosorbent assay was from Shino Test
(Tokyo, Japan).
Hepatic Adenosine Triphosphate Content
Liver samples were frozen immediately in liquid ni-
trogen. The frozen tissue was powdered, homogenized in
HEPES buffer (25 mmol/L HEPES, 10 mmol/L MgCl2, 0.02%
NaAc), and incubated for 10 minutes with 150 L 6% trichlo-
racetic acid (Sigma, Buchs, Switzerland) and 100 L adeno-
sine triphosphate (ATP) releasing reagent (FLSAR; Sigma).
The supernatant was analyzed in a luminometer (Labsystems
Luminoscan 1.2-0; Labsystems, Helsinki, Finland) after addi-
tion of 50 L of ATP monitoring reagent (Luciferase; Pro-
mega, Dübendorf, Switzerland). ATP concentrations were cal-
culated from a calibration curve using pure ATP (disodium
salt hydrate; Sigma) for each experiment.
Western Blotting
The following antibodies were used for immunoblots:
Cdk1, pCdk1Tyr15, c-Jun, pc-JunSer63, Akt, pAktSer473 (all from Cell
Signaling, Allschwil, Switzerland), p21 (from BD Pharmingen),
pp21Thr57, pp21Thr145, pp21Ser130, pp21Ser146 (all from Biorbyt,
Cambridge, United Kingdom), p27 (from Santa Cruz), and -
tubulin (from Abcam). The procedure was performed as de-
scribed.8
Quantitative Real-Time Polymerase Chain
Reaction
Total RNA was extracted from 50 mg of liver tissue using
TRIzol reagent (Invitrogen, Basel, Switzerland) following themanufac-
turer’s instructions. After generation of complementary DNA
(ThermoScript reverse-transcription polymerase chain reaction sys-
tem; Invitrogen), quantitative real-time polymerase chain reaction am-
plification and data analysis were performed on the ABI Prism 7000
Sequence Detector System (PE Applied Biosystems, Rotkreuz, Switzer-
land). TaqMan gene expression assays (PE Applied Biosystems) for
Ccnd1 (Mm00432359_m1), Ccne1 (Mm00432367_m1), Ccna2
(Mm00438064_m1), Ccnb2 (Mm01171453_m1), p21 (Mm0130
3209_m1), p27 (Mm00438168_m1), p16 (Mm00494449_m1), p19
(Mm00486943_m1), Il6 (Mm00446190_m1), Tnfa (Mm0044
3258_m1), Myc (Mm00487803_m1), Hgf (Mm01135190_m1),
Foxm1b (Mm00514924_m1), Skp2 (Mm00449925_m1), and Cks1b
(Mm01617993_gH) were used and normalized to 18S rRNA (control
reagents; PE Applied Biosystems). The results shown represent fold
induction over sham controls.
Flow Cytometry
DNA ploidy was determined from frozen liver specimens
as described.9
Statistical Analysis
There were 6 animals per group unless specified otherwise.
Data are given as mean  standard deviation. Differences between
the groups were assessed by a 2-tailed t test assuming unequal
variance. The level of statistical significance was set at a P value of
less than .05. Statistical analyses were performed using Prism 4.0
(GraphPad, San Diego, CA). Significant values were included in the
figures.
Results
Extended Hepatectomy Induces Liver Failure
in Mice
To provoke a murine entity reminiscent of human
SFSS, extended 86% hepatectomy (eHx) was performed on
C57Bl/6 mice with ligature of the vascular pedicle before
resection (Figure 1A and B). This modification was per-
formed to protect critical structures from close mass lig-
atures and to reduce blood loss. The outcome was com-
pared with the standard model of pHx, which induces
active liver regeneration. In contrast to pHx after which
no increase in cholestatic parameters was observed, hyper-
bilirubinemia persisted after the extended resection (Fig-
ure 1C and D). Serum albumin level was decreased signif-
icantly at 48 hours (Figure 1E), consistent with an
impaired liver function after eHx. Notably, the majority of
mice (7 of 10) survived after extended resection (Figure
1F). Therefore, the modified 86% hepatectomy induces
symptoms akin to human SFSS without causing excessive
mortality.
Liver Failure After Extended Hepatectomy in
Mice Is Not Associated With Significant Liver
Injury
The low mortality in our experimental SFSS model
suggests that parenchymal injury levels may be low after the
modified eHx. We hence assessed liver integrity after resec-
tion. Although serum alanine aminotransferase and high-
mobility group protein 1 levels,10 markers of hepatic injury,
were increased slightly in the eHx relative to the pHx group
at 48 hours after resection, the magnitude of the changes
remained low (Figure 2A). Liver parenchyma 2 days after eHx
did not show any gross abnormalities on histology (Figure
2B). Apart from a microsteatotic change, the liver architec-
ture appeared intact, without signs of an accelerated inflam-
matory reaction. Accordingly, the M1 macrophage marker
F4/80 was not increased in the livers of eHx relative to pHx
animals (Figure 2B). Further, expression of the neutrophil
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marker Mpo was negligible in both groups (Figure 2B). In
line with the low neutrophil infiltration, we failed to identify
substantive necrotic areas (Figure 2B). Likewise, only a few
TUNEL-positive hepatocytes were detected at 48 hours in
both groups (Figure 2B), consistent with an absence of sig-
nificant cell death. No shedding of the sinusoidal lining was
observed by immunohistochemistry using the sinusoidal
markers vascular endothelial growth factor receptor 3 and
Cd31 (Figure 2B). Moreover, energy content, as assessed by
the level of intrahepatic ATP level, was similar in the 2
groups (Figure 2C). Finally, we did not observe any differ-
ences in the amount of Malondialdehyde (Figure 2C), a
marker of lipid peroxidation and an indicator of oxidative
stress.
Altogether, these results indicate that after eHx mice do
not suffer from excessive damage leading to hepatocyte
death and progressive liver failure. The extended resection
of the liver as performed in our model does not cause
pathologic changes apart from transient cholestasis, liver
dysfunction, and microsteatosis.
Extended Hepatectomy in Mice Results in a
Marked Delay in Liver Regeneration
Given the absence of serious liver injury in our
model, we next sought to study the capacity of the liver to
regenerate after eHx. Overall, regeneration is reflected in
the gain of liver mass and was assessed by the LW/BW
ratio at different time points after resection. After stan-
dard hepatectomy, animals typically restored their liver
mass very rapidly (within a week). In contrast, the gain
in LW/BW was reduced and markedly delayed between
48 and 96 hours after extended resection (Figure 3).
Thus, despite the absence of significant injury, liver
regeneration appears to be seriously affected by ex-
tended resection.
Figure 2. Absence of exces-
sive parenchymal injury after ex-
tended hepatectomy. (A) Serum
alanine aminotransferase (ALT)
and high-mobility group protein
1 (Hmgb1) levels at 48 hours af-
ter resection. Note the absolute
levels of ALT. Necrotic cell death
leads to an increase of both se-
rum ALT and Hmgb1 level. (B)
Formalin-fixed, paraffin-embed-
ded liver sections 48 hours after
resection stained with H&E,
against F4/80, Mpo, for DNA
fragmentation (TUNEL), and the
sinusoidal markers Vegfr3 and
CD31. Note the absence of his-
tologically evident tissue injury.
(C) Intrahepatic ATP and MDA
levels at 48 hours after resection.
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Extended Resection Retards the Progression
Through the Cell Cycle
To explore potential mechanisms underlying the
deficient regeneration, we examined the expression of pro-
liferation markers after resection. In mice, maximal hepa-
tocyte proliferation and mitosis usually is observed 48
hours after hepatectomy.11 Surprisingly, the proliferative
index assessed by Ki67 appeared to be higher in eHx than
pHx mice at 24–72 hours after resection, albeit this dif-
ference was not significant (Figure 4A). The S-phase
marker PCNA was increased slightly at 24 and 32 hours in
eHx relative to pHx mice (Figure 4B). Apart from the
32-hour time point, the eHx group displayed a nonsignif-
icant increase in the number of hepatocyte nuclei positive
for pH3, a marker associated with the G2- and M-phases
of the cell cycle (Figure 4C). In contrast to the pHx group,
however, large nuclei strongly positive for pH3 were ab-
sent in eHx mice at 48 hours after resection (Figure 4C),
suggesting a deficit affecting the mitotic chromatin
changes. Conversely, at 96 hours, bold pH3 nuclei essen-
tially were absent in the pHx group, but appeared in the
eHx group. These changes were paralleled by the number
of mitotic figures, which strongly were reduced at 48
hours, but significantly increased relative to pHx mice at
96 hours when eHx animals regained liver weight (Figures
3 and 4D). Consistent with the latter, Ki67 and PCNA
both were increased in eHx mice at 96 hours after resec-
tion (Figure 4A and B). These results suggest that hepa-
tocytes do enter the cell cycle after extended resection, but
delay progression to mitosis. In support of this observa-
tion, the number of cells with a tetraploid and higher
DNA content peaked at 48 hours after pHx, but remained
increased at 72 and 96 hours after eHx (Figure 4E, Sup-
plementary Figure 1). In addition, the percentage of cells
with a 2–4 N DNA content was increased slightly in eHx
compared with pHx animals at 24 and 32 hours (paral-
leled by a slightly increased and reduced percentage of
cells with a 2 N and 4 N content, respectively), suggest-
ing some accumulation of eHx cells in the S-phase. There-
fore, extended resection appears to provoke an inefficient
progression through the initial S-phase, followed by a
transient arrest at the G2/M border.
Extended Resection Down-Regulates the
S- and M-Phase Promoter Foxm1b and
Up-Regulates p21
Given the absence of significant hepatocyte death,
the failure of hepatocytes to divide is the likely reason for
the blunted regeneration after extended hepatectomy. We
assessed in the liver remnants the expression of cell-cycle
regulators after resection. We first measured the messen-
ger RNA (mRNA) expression of the cyclins Ccnd1, Ccne1,
Ccna2, and Ccnb2 (Figure 5A) associated with driving the
entry into cell cycle, the G1-phase, S-phase, and M-phase,
respectively.12 At 24 and 32 hours after resection, Ccne1
and Ccnd1 expression, respectively, were increased signifi-
cantly in the eHx compared with the pHx group, likely
reflecting the strong proliferative response to extended
resection as insinuated by the Ki67 index. At 32 hours, the
usual S-phase peak, Ccna2 was down-regulated in eHx
mice, consistent with a slower progression through repli-
cation. At 32 and 48 hours, when mitosis was repressed,
Ccnb2 was down-regulated markedly in eHx mice. Cyclin B
forms a complex with Cdk1 to act as a master driver of
mitosis.13 At 48 hours after eHx (the mitotic peak), Cdk1
activity likewise was reduced as evinced by an increased
inhibitory phosphorylation of Cdk1 at Tyr14/15 (Figure
5B). At 72 hours after resection, Ccnd1, Ccne1, and Ccna2
were overexpressed in eHx mice, in accordance with the
accelerated LW/BW gain evident after 96 hours after eHx.
Consistent with the lack of deficiencies in G1 cyclins,
activation/induction of early cell-cycle promoters (Il-6,
Tnfa, Myc, Hgf, c-Jun, Akt) was normal or tended to be
increased after eHx (Supplementary Figure 2). In contrast,
Foxm1b, a key promoter of the S- and particularly M-
phase during regeneration,14 was induced suboptimally at
32 and 48 hours after eHx (Figure 5C). We next deter-
mined the expression levels of several cyclin-cdk complex
inhibitors (Supplementary Figure 3). Of those, only p21, a
repressional target of Foxm1b,14 was deregulated in eHx
Figure 3. LW/BW ratio during
the first week after standard and
extended resection. (A) The
LW/BW indicates a markedly
suppressed liver weight gain be-
tween 48 and 96 hours after ex-
tended hepatectomy. (B) Body
weight loss was stronger after
eHx than pHx, increasing the
LW/BW in eHx mice.
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mice. Although mRNA levels were up-regulated at 24–72
hours, protein was increased markedly at 32 and 48 hours
after eHx (Figure 5D, Supplementary Figure 4). Protein
accumulation was accompanied by differential phosphor-
ylation at several sites associated with protein stability,15
suggesting complex regulation through multiple kinases.
p21 levels further inversely correlated with those of Skp2
and Cks1b (Figure 5C), both of which are activated by
Foxm1b to target p21 for proteasomal degradation, en-
abling cell-cycle progression during liver regeneration.16
Therefore, extended hepatectomy does not inhibit the
entry into, but rather the progression through, the cell
cycle. This delay is accompanied by a deficient induction
of Foxm1b and its targets Ccna2, Ccnb2, Skp2, and Cks1b,
concomitant with p21 up-regulation and a reduced acti-
vation of the M-phase–specific cyclin B-cdk1 complex.
Figure 4. Proliferation markers
and DNA ploidy in liver remnants
after resection. (A) The percent-
age of Ki67- and (B) PCNA-pos-
itive cells after resection. (C)
Liver sections at 48, 72, and 96
hours after resection stained for
pH3. Note the prominent, bold
nuclei in pH3 stains of pHx mice
at 48 hours. (D) Number of hepa-
tocytes undergoing mitosis per
high-power field (HPF). (E) Time
course of DNA ploidy changes
after resection. 2 N, G1-phase
cells; 2–4 N, S-phase cells; 4
N, G2/M-phase cells. Error bars
refer to standard deviation. In-
dividual ploidy graphs are shown
in Supplemental Figure 1.
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Figure 5. Expression of cell-cycle–associated molecules in liver of hepatectomized mice. (A) Quantitative polymerase chain reaction for the
expression of the cyclin genes Ccnd1, Ccne1, Ccna2, and Ccnb2. (B) Inhibition of Cdk1 activity as assessed by the ratio of p-Cdk1 vs total Cdk1
protein levels derived from immunoblots 48 hours after resection. (C) Quantitative polymerase chain reaction for the expression of Foxm1b and its
downstream targets Skp2 and Csk1b. (D) Quantitative polymerase chain reaction for p21 gene expression (mRNA) and densitometric analysis of p21
total and phosphoprotein immunoblots (protein). Total protein levels were normalized to -tubulin, and phosphoprotein levels were normalized to
total protein. Fold induction was calculated relative to p21 levels in sham-operated animals (see Supplementary Figure 4).
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Inhibition of p21 Restores the Regenerative
Capacity and Ameliorates SFSS Features After
Extended Hepatectomy
Through sequestering PCNA from replication sites
and keeping cyclin-cdk complexes in an inactive state, p21
inhibits the cell cycle and may effectuate the regenerative
delay after eHx.15 To test whether p21 contributes to the
pathogenesis of experimental SFSS, we subjected p21/
mice and matched wild-type mice (B6129SF2/J) to 86%
hepatectomy.
In p21/ animals, the abnormal pH3 staining observed
in wild-type mice after eHx was restored (Figure 6A) and
paralleled by mitotic activities similar to those seen in
wild-type mice after standard hepatectomy (Figures 4D
and 6B). In addition, p21 deficiency further increased the
number of Ki67- and PCNA-positive hepatocytes after
eHx (Figure 6B). Consequently, the LW/BW significantly
improved in knockout animals between 48 and 96 hours
after eHx (Figure 6C). The accelerated gain in liver weight
was accompanied by normalized serum albumin levels
(Supplementary Figure 5). Bilirubin level, however, re-
mained increased in the knockout animals (Supplemen-
tary Figure 5). To confirm the superior outcome in p21/
mice, survival was assessed. B6129SF2/J wild-type mice
were more susceptible to eHx than the C57Bl/6 strain
(50% vs 70% survival for C57Bl/6). Nonetheless, p21
deficiency improved the survival of B6129SF2/J mice to
85% after extensive resection (Figure 6D).
Altogether these results indicate that p21 mediates a
transient physiological barrier to the progression through
and completion of the cell cycle, inhibiting liver regener-
ation, and, ultimately, deteriorating survival after ex-
tended resection of the liver.
Discussion
Under physiologic conditions, the liver has an un-
matched potential to regenerate after major tissue loss. In
mice, restoration of the initial liver mass usually is com-
pleted within a few days.17 If tissue loss is too extensive,
resection can lead to acute liver failure in mice, akin to
human SFSS.4–7 Whether a diminished regenerative ca-
pacity of small liver remnants contributes to liver failure
is unclear. Blunted regeneration leading to hepatic dys-
function has been observed in different mouse models of
extended resection.4–7,18 In all these models, however, re-
section was accompanied by excessive hepatic injury,
which is likely to impact the regenerative capacity of the
Figure 6. Liver regeneration
and survival in wild-type and
p21/ mice after extended
hepatectomy. (A) pH3 staining of
liver remnants at different time
points after extended resection.
Note the prominent, bold, pH3-
positive nuclei in p21/ mice as
seen in wild-type mice after
standard resection. (B) Number
of mitoses per high-power field
(HPF) and the percentage of
Ki67-/PCNA-positive hepato-
cytes after extended resection in
wild-type and p21/ mice. (C)
Gain in liver weight after ex-
tended resection. Note the ac-
celerated gain starting in p21/
mice at 48 hours after eHx. (D)
Kaplan–Meier estimates for the
survival of wild-type and p21/
mice after extended resection.
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liver remnant. Furthermore, some of the existing models
included exposure to ischemia-reperfusion,5,18 augment-
ing the severe parenchymal injury. To study the intrinsic
regenerative capacity of a small remnant after extended
hepatectomy, exposure of the liver to any confounding
damage (including injury to vascular or biliary structures)
hence should be minimized.
Here, we modified extended hepatectomy in mice, en-
abling radical but safe resection of the liver. The adjusted
procedure allowed for the study of resection-induced liver
regeneration in the absence of significant damage, and iden-
tified inhibition of cell-cycle progression as a key mechanism
driving the development of experimental SFSS.
After eHx, mice displayed features typically found in
human SFSS, such as persistent hyperbilirubinemia and
reduced hepatic function. Importantly, these features de-
veloped in the absence of significant liver damage, imply-
ing the latter is not an obligate component of experimen-
tal SFSS. We examined hepatic histology, sinusoidal
integrity, energy content, and markers of hepatic injury,
inflammation, oxidative stress, and cell death. Altogether,
we did not observe resection-induced damage that may
lead to a functional deficit of the small liver remnant.
Consequently, survival was improved. Some of this im-
provement might relate to strain-specific susceptibilities
of mice toward hepatectomy, which we observed in our
study (ie, C57Bl/6 vs B6129SF2/J).
The key question of this study was whether a small liver
remnant per se retains its ability to regenerate. In the
absence of confounding injury, we observed a reduced
capacity of the liver to regain weight after eHx. Unexpect-
edly, the deficient regeneration was accompanied by a
normal initial induction of the G1-phase cyclin D, an
increased induction of the G1  S-phase cyclin E, and by
the tendency of increased numbers of Ki67- and pH3-
positive cells. Likewise, molecules governing entry into the
cell cycle were induced normally (Akt, Tnfa, Hgf) or tended
to be overexpressed (Myc, Il6, pc-Jun) early after eHx.
Thus, extended hepatectomy appears to induce a strong
proliferative signal that pushes hepatocytes to enter the
cell cycle and to proceed into the S-phase. Here, DNA
ploidy and PCNA analyses both pointed to an increased
number of replicating cells whereas Ccna2 levels were
reduced, implying a stalled progression through S after
eHx. A more serious defect, however, was indicated by the
lack of bold pH3-positive nuclei and the marked paucity
of mitoses at 48 hours after eHx. These deficiencies imply
that hepatocytes become arrested before they condense
their chromatin to mitotic chromosomes. Consistent with
an arrest at G2/M is the suppressed activity of the essential
driver through cellular mitosis,12 the cyclin B-cdk1 com-
plex, at 48 hours and a persistence of tetraploid (4 N)
cells at later times after eHx. In support, we observed a
deficient induction of Foxm1b, known to promote repli-
cation and to be essential for mitosis after hepatectomy.14
Failure of mitotic progression conceivably explains the
deficient regeneration of liver after extended resection. Of
note, Foxm1b and Ccnd1/e1/a2 were re-induced whereas
Ccnb2 increased to normal levels 72 hours after eHx.
Foxm1b is a direct activator of Ccna2/Ccnb214 and hence
may contribute to the re-induction of the cyclins. These
changes were succeeded by an increased mitotic index at
day 4 and a resumption of liver weight gain after day 4
after extended resection. Therefore, the regenerative ca-
pacity of a small liver remnant is not irreversibly lost, but
transiently inhibited, consistent with a physiological sig-
nal mediating the proliferative barrier.
A molecule with a key role in liver regeneration is the
cyclin-cdk complex inhibitor p21.19,20 Notably, p21 is
thought to counterbalance regenerative signals also under
pathophysiological conditions, such as acute liver fail-
ure.21 In our model, p21 protein was markedly up-regu-
lated during the usual S- and G2/M-phases after eHx. Its
removal restored normal mitotic activity, expedited liver
regeneration, and improved survival after extended resec-
tion. These findings emphasize the central role p21 has in
limiting the regenerative response after extended hepatec-
tomy.
The marked up-regulation of the molecule suggests a
specific involvement of p21 in the regenerative defect of
our experimental SFSS model. The changes in Foxm1b, a
direct repressor of Cdkn1a during liver regeneration,14
support such a role. Foxm1b deficiency not only may
increase p21 mRNA, but also protein levels through the
insufficient induction of Skp2/Csk1b, part of the ubiquitin
ligase complex that marks p21 for proteasomal degrada-
tion during cell-cycle progression after hepatectomy.16
Likewise, Foxm1b deficiency may account, at least in part,
for the low levels of Ccna2/b2 at 32 and 48 hours after
eHx.14 Other molecules that participate in p21 regulation
after hepatectomy may be the kinases responsible for the
differential phosphorylation pattern of p21 after eHx.
Phosphorylation at these sites has been associated vari-
ously with both p21 stabilization or degradation.15 Al-
though the significance of p21 modification in liver re-
generation is unknown, the differential phosphorylation
further supports a specific role for p21 in experimental
SFSS.
On the other hand, p21 is known to be a general
determinant of regenerative potential,22,23 and its defi-
ciency may simply override the negative growth signals in
our model. Indeed, some unspecific contribution is
evinced by the further induction of Ki67-/PCNA-positive
cells (that were not reduced after eHx) upon removal of
p21. Therefore, although p21 may be a part of the specific
molecular defect underlying our experimental SFSS
model, other negative signals are likely to contribute, with
the complete removal of p21 adding unspecific regenera-
tive potential to critically small liver remnants.
Consistent with our above statement, we note that p21
deficiency did not completely restore regeneration and
survival after extended resection. All metabolic features
(eg, bilirubinemia) were completely reversed either in p21-
deficient mice. Therefore, additional mechanisms must
act to hinder full recovery of small liver remnants. Such
factors perhaps relate to a defective excretory function,
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reflected by the mild bilirubinemia persisting in p21/
mice. Alternatively, and given the use of constitutive mu-
tants, other antiproliferative signals might have compen-
sated for the lack of p21 to some extent.
However, our findings show that the p21-mediated in-
hibition of liver regeneration is a decisive factor for the
survival of extended hepatectomy. Importantly, by sepa-
rating excessive hepatocyte injury from hepatectomy in
mice, we could show that a key parameter limiting the
survival is related to physiological mechanisms. Severe
damage may be prevented, but once present it likely is
irreversible. In contrast, our results indicate that the de-
celeration of liver regeneration is transient and hence
could be overcome in principle. Given that the main
proliferative deficit affects the G2-/M-cell cycle phase, its
relatively late manifestation might provide a window of
therapeutic opportunity. For p21 to be of therapeutic
value, it will be essential to understand the deregulated
pathways that lead to the up-regulation of p21 after
extended resection. A limited and transient suppression of
p21 might be beneficial. However, consideration is needed
of the roles p21 has in the termination of liver regenera-
tion,20 and, more so, in the suppression of malignancy.24
How eHx may lead to p21 up-regulation currently is
unclear. Relative to pHx, extended resection conceivably
will provide a strong regenerative trigger. In support, we
observed a trend toward increased levels of early promot-
ers of liver regeneration (ie, Il6, Myc, Ccne1, pc-Jun), along
with a higher number of Ki67- and pH3-positive nuclei.
Thus, massive parenchymal loss might induce an exuber-
ant proliferation signal that exceeds the available regen-
erative capacity. To counterbalance exaggerated regenera-
tion, hepatocytes might respond by slowing proliferation
via p21. Indeed, sustained activation of molecules that
usually initiate liver regeneration (eg, Erk1/2) can result in
Cdkn1a up-regulation, Foxm1b repression, and cell-cycle
arrest.25,26 Assuming the presence of additional p21 de-
grading signals at early times after eHx (eg, through de/
phosphorylation), such a scenario would be consistent
with an early increase in the Cdkn1a message that trans-
lates into increased protein levels predominantly around
the S- and G2/M-phase where Foxm1b normally would
promote p21 degradation through the induction of Spk2/
Csk1b. Intriguingly, reducing the regenerative speed by
pharmacologic inhibition of Erk1/2 at early times has
been shown to improve survival after extended hepatec-
tomy.27
In conclusion, we have designed a novel mouse model
for the study of regeneration after extended hepatectomy
by improving the safety of surgical resection. In our
model, failure of regeneration develops in the absence of
serious parenchymal injury, indicating the latter is not an
intrinsic feature of experimental SFSS. The dissociation of
injury revealed that small liver remnants have a reduced
capacity to regenerate. This failure is mediated by a tran-
sient, p21-dependent barrier to cell-cycle progression,
with a marked accumulation of cells before mitosis. Re-
moval of p21 lifts this barrier, accelerates regeneration,
and ameliorates survival after extended resection.
Therefore, failure of cell-cycle progression in liver re-
generation is a key mechanism and can be overcome by
inhibition of p21.
Supplementary Material
Note: To access the supplementary material
accompanying this article, visit the online version of
Gastroenterology at www.gastrojournal.org, and at http://
dx.doi.org/10.1053/j.gastro.2012.08.043.
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Supplementary Figure 1. Hepatic DNA ploidy profiles after pHx and
eHx. Bar charts showing the percentage of hepatic cells with a 2 N, 2–4
N, and 4 N DNA content at different times after standard (68%) or
extensive resection (86%). The right bars show the percentage of cells
with a tetraploid DNA content (4 N) or higher (4 N). P values indicate
significant differences in DNA content distribution between eHx and
pHx animals. A minimum of 10,000 cells were analyzed per sample. All
cells were included into analysis apart from cells with a 2 N DNA
content. The 2 N, 2–4 N, and 4 N populations had a median peak
intensity of 2.7104, 5.5104, and 11104, respectively. Three to 5
animals/group were analyzed. Error bars show  standard deviation.
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Supplementary Figure 2. Expression of early promoters of liver regeneration after pHx and eHx. The expression of Il6, Myc, Tnfa, and Hgf was
assessed by quantitative polymerase chain reaction (PCR). Error bars indicate standard deviation. The activity of c-Jun and Akt proteins at 8 hours
after resection was assessed by immunoblots using phospho-specific antibodies. Five mice per group were used. Note the pc-Jun expression
tended to be increased in eHx animals.
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Supplementary Figure 3. Expression of cell-cycle inhibitors after hepatectomy. The expression of p16, p19, and p27 was assessed by quanti-
tative polymerase chain reaction (PCR). Error bars show standard deviation. For p27, expression also is shown on immunohistochemistry and by
immunoblots (5 mice/group) at 48 hours after resection. The p27 control shows positive p27 expression in differentiated intestinal cells.
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Supplementary Figure 4. p21 total and phosphoprotein levels after standard (68%) and extended (86%) resection. Immunoblot bands show
representative levels of p21 protein and its phosphorylation pattern at various times after pHx and eHx as determined from 4–6 animals/time point.
S, bands from sham-operated animals. The lower panels show p21 immunofluorescence on paraffin-embedded, formalin-fixed sections from liver.
Nuclei were counterstained with 4=,6-diamidino-2-phenylindole (DAPI) (blue). Note the nuclear localization of p21 in eHx mice.
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Supplementary Figure 5. Cholestatic and liver function markers in
p21/ mice after extended hepatectomy. Serum albumin and bilirubin
levels at 48 hours after eHx in p21/mice. Error bars show standard
deviation.
Month 2012 P21–DEPENDENT BARRIER TO LIVER REGENERATION 11.e4
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
